Victoria Heart Institute Foundation, Victoria, British Columbia, Canada.
Victoria Heart Institute Foundation, Victoria, British Columbia, Canada; University of Alberta, Edmonton, Alberta, Canada.
Can J Cardiol. 2018 Aug;34(8):983-991. doi: 10.1016/j.cjca.2018.04.030. Epub 2018 May 5.
Coronary artery bypass grafting (CABG) is established treatment for subsets of coronary artery disease (CAD). Observational data have characterised significant progression of native coronary as well as graft vessel disease during longer-term follow-up, potentially reducing the benefit of CABG. We sought to assess longer-term outcomes following CABG by determining rates of repeat coronary angiography, revascularization procedures, and survival.
Data for all patients undergoing isolated CABG in British Columbia between 2001 and 2009 inclusive, and with follow-up until the end of 2013, were retrieved from the British Columbia Cardiac Registry. Cox proportional hazard regression and competing risk regression were performed for survival and subsequent cardiac procedures (coronary angiography, percutaneous coronary intervention [PCI] or repeat CABG).
Data were available from 17,316 patients with a mean age at index CABG of 65.7 ± 9.8 years. At a median follow-up of 8.5 (range 4.0 to 12.9) years, 3185 patients (18.4%) had died, 3135 (18.1%) underwent repeat coronary angiography with or without PCI or repeat CABG, and 11,557 (66.7%) had survived without additional procedures. Of those who underwent angiography, 1459 patients (46.5%) underwent further revascularization. In multivariate analysis, the strongest predictors of long-term mortality were dialysis dependency and age >75, whereas left internal mammary artery utilization and aspirin therapy were protective. Repeat revascularization predicted survival (adjusted hazard ratio 0.76; 95% confidence interval, 0.63-0.92; P = 0.004), whereas angiography alone did not.
Following CABG, patients frequently undergo repeat coronary angiography. Although only a minority of patients receive further revascularization, this appears to be associated with longer-term survival.
冠状动脉旁路移植术(CABG)是治疗冠状动脉疾病(CAD)亚组的既定治疗方法。观察性数据表明,在较长时间的随访中,原生冠状动脉和移植物血管疾病会显著进展,从而降低 CABG 的获益。我们试图通过确定重复冠状动脉造影、血运重建程序和生存率来评估 CABG 后的长期结果。
从不列颠哥伦比亚心脏登记处检索了 2001 年至 2009 年期间在不列颠哥伦比亚省接受单纯 CABG 治疗且随访至 2013 年底的所有患者的数据。采用 Cox 比例风险回归和竞争风险回归分析生存率和随后的心脏程序(冠状动脉造影、经皮冠状动脉介入治疗[PCI]或再次 CABG)。
17316 例患者的数据可用,指数 CABG 时的平均年龄为 65.7 ± 9.8 岁。在中位数为 8.5 年(范围为 4.0 至 12.9 年)的随访中,3185 例患者(18.4%)死亡,3135 例患者(18.1%)接受了冠状动脉造影,伴有或不伴有 PCI 或再次 CABG,11557 例患者(66.7%)未接受额外治疗而存活。在接受血管造影的患者中,1459 例患者(46.5%)接受了进一步的血运重建。多变量分析显示,长期死亡率的最强预测因素是透析依赖和年龄>75 岁,而左内乳动脉利用和阿司匹林治疗具有保护作用。重复血运重建预测生存率(调整后的危险比 0.76;95%置信区间,0.63-0.92;P=0.004),而单纯血管造影则不然。
CABG 后,患者经常接受重复冠状动脉造影。尽管只有少数患者接受进一步的血运重建,但这似乎与长期生存有关。